CEO Edward Ludwig

Filed under: Stocks to Buy Medical equipment giant Becton Dickinson’s (NYSE: BDX ) stock has meandered since recommended on March 17, 2009 at a price of $65.66, with volatility, most likely due to U.S. federal health care reform legislation uncertainty, but look for better quarters ahead, when the dust settles, which is why I’m reiterating my Buy rating for the company’s shares. In FY2010, Becton’s revenue growth should total about 5-7%, after essentially flat revenue in FY2009 Read the original here: Sideways stock movement likely over for Becton Dickinson Read Full Story

All investors must decide whether they want their portfolio to compete in a sprint, a marathon or something in between. The kind of stocks that succeed in a sprint can be a disaster in the long run, and vice versa. Medical supplies provider Becton Dickinson BDX is a marathon runner. Its earnings have increased every year for at least 20 years. Its sales have risen for 19 years in a row. And it has raised its dividend for 36 straight years. Analysts see the EPS and sales streaks continuing in fiscal 2009, ending in September. They see EPS rising 10% while sales edge up ... Read Full Story

Mechanical Design Engineer Medical Surgical Systems at Becton Dickinson and Company Sandy Utah Description Mechanical Design Engineer, Medical Surgical Systems-MEC1001Z BD, a leading global medical technology company that makes and sells medical devices, instrumented systems and reagents, is dedicated to improving people?s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed [...] Read Full Story

IN THE PINK AT BECTON DICKINSON Since hitting a 52-week low of 58.14 on Nov. 21, Becton Dickinson (BDX) has perked up before closing at 66.42 on Apr. 8. One reason: The medical supplies, devices, and diagnostic-systems company posted fiscal first-quarter results that surprised analysts. Its robust earnings of $1.26 a share "made a mockery of our $1.11 forecast and beat the consensus by 11 cents," concedes Bank of America/Merrill Lynch's Jon Wood in a report. So he has increased his earnings estimate for fiscal 2009 (ending on Sept. 30) to $4.95 a share from $4.90, and his 12-month price target to 95 from ... Read Full Story

Interview and discussion with Jim Tierney of the W.P. Stewart & Co. He talks about Warren Buffett's bet on Becton Dickinson stocks. (Bloomberg News) Read Full Story